Zydus Lifesciences receives U.S. FDA approval for Scopolamine Transdermal System
Zydus gains final approval to market Scopolamine Transdermal System, marking its fifth ANDA approval in the transdermal portfolio…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.